RNAC
Cartesian Therapeutics Inc.
7.90$
-1.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.50 | 0.47 | 27.73 | 0.36 | 1.45 | 5.28 | 5.90 | 26.79 | 27.34 | 5.03 | 1.64 | 0.11 | |
| 49.17 | 1.13 | 52.49 | 79.61 | 76.68 | 33.78 | – | – | 0.50 | 0.30 | – | – | |
| 8.50 | 0.47 | 27.73 | 0.36 | 1.45 | 5.28 | 5.90 | 26.79 | 26.84 | 5.03 | 1.64 | 0.11 | |
| 29.34 | 1.79 | 101.89 | 79.61 | 76.68 | 33.78 | 19.39 | 21.64 | 17.86 | 13.78 | 1.90 | 2.23 | |
| 22.25 | 0.65 | 44.77 | 33.18 | 29.33 | 12.95 | 6.73 | 6.59 | 5.89 | 7.82 | 1.27 | 1.21 | |
| 51.58 | 2.35 | 143.92 | 111.47 | 104.43 | 46.74 | 26.12 | 28.24 | 23.25 | 21.74 | 3.50 | 3.45 | |
| -43.08 | -1.97 | -118.94 | -112.42 | -104.55 | -41.46 | -20.21 | -1.45 | 3.59 | -16.71 | -1.85 | -3.34 | |
| 1.54 | 0.07 | 4.30 | 2.13 | 2.40 | 1.20 | 0.55 | 0.90 | 0.75 | 0.55 | 0.00 | – | |
| -36.03 | -1.96 | -124.22 | -115.13 | -105.05 | -43.75 | -24.50 | -3.06 | 8.58 | -46.17 | -3.26 | -5.37 | |
| 1.42 | 0.07 | 1.56 | 0.54 | 0.00 | 1.47 | 0.59 | 5.03 | -0.15 | -3.67 | 0.01 | -0.35 | |
| -36.03 | -1.96 | -124.22 | -115.13 | -105.05 | -43.75 | -24.50 | -8.09 | 8.73 | -42.49 | -3.27 | -5.02 | |
| -32.07 | -1.80 | -117.17 | -111.68 | -101.08 | -40.94 | -23.33 | -1.62 | 9.83 | -45.46 | -3.21 | -5.26 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.